- Why the MGP Blueprint Has 17 Domains
- The 17 MGP Content Domains at a Glance
- Foundational Domains: Structure, Principles, and Methods (Domains 1-7)
- Disease-Focused Domains: Where the Exam Concentrates (Domains 8-13)
- Specialized and Operational Domains (Domains 14-17)
- Building a Domain-Weighted Study Schedule
- How Domain Weighting Should Shape Your Registration Timeline
- Who Relies on This Domain Map After Certification
- Frequently Asked Questions
- The 2026 MGP blueprint has 17 domains spread across a 245-question, six-section exam.
- Solid Tumors (11%), Inherited Diseases (10%), and Hematopathology (9%) are the three heaviest domains.
- Passing requires a scaled score of 500, not a percentage of correct answers.
- Histocompatibility (2%) and Management and Informatics-General (3%) are the lowest-weighted domains.
Why the MGP Blueprint Has 17 Domains
The Molecular Genetic Pathology exam, jointly overseen by the American Board of Pathology (ABPath) and the American Board of Medical Genetics and Genomics (ABMGG), is not organized around a handful of broad topics. Instead, the 2026 content specification breaks the exam into 17 distinct domains, each with its own approximate weight. This structure exists because MGP sits at the intersection of molecular biology, cytogenetics, oncology, hematopathology, and laboratory operations - a candidate cannot be tested fairly on "genetics" alone.
The 2026 exam schedule delivers 245 questions across six sections, with 6 hours 34 minutes of active testing time inside a 9 hour 4 minute scheduled day that includes instructions, a survey, and breaks. Every one of those 245 questions maps back to one of the 17 domains below. Understanding how the blueprint allocates those questions is the single most useful thing you can do before you open a review book, because it tells you exactly where your study hours will pay off.
The 17 MGP Content Domains at a Glance
Below is the full 2026 domain list with approximate percentage weights, ordered exactly as they appear in the official blueprint. These are approximate allocations, not guarantees for any single form of the exam, but they are the best available guide to where questions concentrate.
| # | Domain | Approx. Weight |
|---|---|---|
| 1 | Normal Structure and Function | 7% |
| 2 | Molecular Genetic Principles | 7% |
| 3 | Techniques and Methods | 5% |
| 4 | Assay Performance and Validation | 7% |
| 5 | Quality | 6% |
| 6 | Ethical, Legal, and Regulatory Issues | 5% |
| 7 | Indications for Testing | 4% |
| 8 | Inherited Diseases | 10% |
| 9 | Inherited Cancer Syndromes | 5% |
| 10 | Solid Tumors | 11% |
| 11 | Hematopathology | 9% |
| 12 | Pharmacogenetics | 5% |
| 13 | Infectious Disease | 6% |
| 14 | Identity Testing | 4% |
| 15 | Histocompatibility | 2% |
| 16 | Informatics | 4% |
| 17 | Management and Informatics-General | 3% |
For a broader look at how this blueprint compares to other difficulty factors - pacing, question style, and content density - see our companion piece on how hard the MGP exam actually is.
Foundational Domains: Structure, Principles, and Methods (Domains 1-7)
The first seven domains form the scientific and operational backbone of the exam. Individually none is huge, but together they represent close to 40% of the blueprint - larger than any single disease category. Underestimating this block is one of the most common planning mistakes candidates make.
Domain 1: Normal Structure and Function (7%)
Covers baseline genomic and cellular architecture that every abnormal finding is judged against.
- Normal gene structure, expression, and regulation
- Chromosome organization and normal karyotype variation
- Cell cycle and DNA repair pathways relevant to later disease domains
Domain 2: Molecular Genetic Principles (7%)
Tests the core science underlying every assay result you will later interpret.
- Mendelian and non-Mendelian inheritance patterns
- Mutation types, mosaicism, and penetrance concepts
- Epigenetic mechanisms and their clinical relevance
Domain 3: Techniques and Methods (5%)
Focuses on the laboratory technologies that generate the data you interpret elsewhere on the exam.
- PCR-based methods, sequencing platforms, and array technologies
- FISH, karyotyping, and other cytogenetic techniques
- Strengths and limitations of each platform for specific specimen types
Domain 4: Assay Performance and Validation (7%)
One of the larger foundational domains, testing whether you can judge if an assay is fit for clinical use.
- Sensitivity, specificity, and limit of detection concepts
- Validation versus verification requirements
- Recognizing analytic artifacts versus true positive findings
Domain 5: Quality (6%)
Addresses the quality systems that keep a molecular laboratory compliant and reliable.
- Proficiency testing and quality control principles
- Error detection and corrective action workflows
- Documentation standards expected in an accredited lab
Domain 6: Ethical, Legal, and Regulatory Issues (5%)
Tests judgment on consent, reporting obligations, and regulatory frameworks specific to genetic testing.
- Informed consent nuances for germline versus somatic testing
- Incidental and secondary findings disclosure
- Regulatory oversight of laboratory-developed tests
Domain 7: Indications for Testing (4%)
Checks whether you know when a molecular test is clinically appropriate - and when it is not.
- Matching clinical scenarios to the correct test order
- Recognizing overuse or misuse of molecular assays
- Sequencing of testing strategy (e.g., screening before confirmatory testing)
Key Takeaway
Domains 1 through 7 combine for roughly 41% of the exam. Treat this block with the same seriousness as Solid Tumors or Inherited Diseases - it is not "background" material, it is nearly half the test.
Disease-Focused Domains: Where the Exam Concentrates (Domains 8-13)
This is the block that carries the single heaviest-weighted domains on the entire blueprint. If you only had time to master three topics, these would be the three to prioritize.
Domain 8: Inherited Diseases (10%)
The second-largest domain overall, covering the breadth of germline disorders a molecular pathologist encounters.
- Single-gene disorders across major organ systems
- Trinucleotide repeat expansions and dynamic mutations
- Pedigree interpretation and recurrence-risk reasoning
Domain 9: Inherited Cancer Syndromes (5%)
A distinct domain from general inherited disease, focused specifically on hereditary predisposition to malignancy.
- Major hereditary cancer syndromes and their associated genes
- Germline versus somatic variant distinction in tumor-predisposition genes
- Cascade testing and family-risk implications
Domain 10: Solid Tumors (11%)
The single largest domain on the blueprint. Expect deep coverage of molecular alterations across common and uncommon solid tumor types.
- Actionable driver mutations and companion diagnostic implications
- Fusion detection and structural variant interpretation
- Tumor mutational burden, microsatellite instability, and related biomarkers
Domain 11: Hematopathology (9%)
The third-largest domain, reflecting the central role molecular testing plays in classifying hematologic malignancies.
- Molecular markers used in leukemia and lymphoma classification
- Clonality assessment and minimal residual disease monitoring
- Cytogenetic and molecular correlation in myeloid and lymphoid neoplasms
Domain 12: Pharmacogenetics (5%)
Tests how genetic variation informs drug metabolism, efficacy, and toxicity decisions.
- Common pharmacogenes and their clinical decision-support implications
- Metabolizer phenotypes and dosing consequences
- Integration of pharmacogenetic results into clinical reporting
Domain 13: Infectious Disease (6%)
Covers molecular diagnostics as applied to microbial and viral detection rather than human genome analysis.
- Molecular methods for pathogen identification and viral load
- Resistance mutation testing in relevant pathogens
- Distinguishing infectious-disease molecular questions from human germline or somatic questions on the exam
Specialized and Operational Domains (Domains 14-17)
The final four domains are lower-weighted individually, but together they still represent about 13% of the exam - enough to matter, and often underprepared because candidates assume they are minor.
Domain 14: Identity Testing (4%)
Covers non-disease applications of molecular genetics, including forensic and relationship testing concepts.
- STR-based identity and paternity testing principles
- Chimerism detection in post-transplant monitoring
- Statistical interpretation of identity match probabilities
Domain 15: Histocompatibility (2%)
The smallest domain on the blueprint, but still tested - do not skip it entirely.
- HLA typing methods and nomenclature basics
- Role of histocompatibility testing in transplantation
Domain 16: Informatics (4%)
Focuses on the bioinformatics pipelines and data management underlying modern molecular results.
- Sequence alignment and variant-calling pipeline concepts
- Variant classification frameworks and databases
- Data integrity and interoperability considerations
Domain 17: Management and Informatics-General (3%)
Rounds out the blueprint with laboratory management and general informatics operations.
- Laboratory workflow and staffing considerations
- General information-systems concepts supporting reporting
- Regulatory and accreditation touchpoints for lab management
For a condensed, one-page version of these domain facts you can review the week before test day, see the MGP Cheat Sheet.
Building a Domain-Weighted Study Schedule
Generic study techniques only help if they're pointed at the right material. Because the blueprint tells you exactly how many questions come from each domain, the most efficient approach is to size your study blocks to match domain weight rather than splitting time evenly across all 17 areas.
Heaviest Domains First
- Solid Tumors (11%), Inherited Diseases (10%), Hematopathology (9%)
- Build a variant-interpretation habit before moving to lighter domains
Foundational Science Block
- Normal Structure and Function, Molecular Genetic Principles, Assay Performance and Validation
- These three alone total 21% of the blueprint
Mid-Weight Disease and Method Domains
- Inherited Cancer Syndromes, Infectious Disease, Pharmacogenetics, Techniques and Methods
- Practice distinguishing germline, somatic, and infectious-disease question stems
Quality, Regulatory, and Lower-Weight Domains
- Quality, Ethical/Legal/Regulatory, Indications for Testing
- Identity Testing, Informatics, Management, Histocompatibility as final review
This kind of sequencing - front-loading the largest domains and ending with the smallest - is one piece of a complete prep strategy. For the full methodology, including how to use question banks and timed sections effectively, see the MGP Study Guide.
How Domain Weighting Should Shape Your Registration Timeline
Domain weight isn't just a study-order question - it should also inform when you register and how you budget your preparation window. Because the 2026 initial application/examination fee is USD 2,100 (including a USD 200 nonrefundable administrative fee), most candidates want a clear runway before locking in a test date. Review the MGP Exam Dates page before committing, and check the full fee breakdown in the MGP Certification Cost guide so nothing catches you off guard.
Eligibility also matters here: candidates need qualifying primary ABPath certification (AP/CP, AP, or CP) or eligible ABMGG physician certification, plus 12 months of ACGME-accredited Molecular Genetic Pathology fellowship training. If you're still confirming you meet these prerequisites, the MGP Requirements article walks through each condition in detail. Once you're confident in eligibility and timeline, you can use practice test resources to benchmark your readiness against the same 17-domain structure before you sit the real exam.
Who Relies on This Domain Map After Certification
The 17 domains aren't just an academic exercise - they describe the actual scope of work MGP-certified physicians perform once hired. Molecular genetic pathologists interpret solid tumor and hematopathology panels, validate new assays, oversee laboratory quality systems, and advise on inherited disease and pharmacogenetic results - directly mirroring Domains 3 through 13 of the blueprint. If you're exploring where this certification leads professionally, the MGP Jobs overview and our MGP Salary Guide connect these domains to real-world laboratory and academic roles.
Certification also isn't a one-time event. ABPath certificates carry no fixed expiration date but remain conditional on Continuing Certification participation, including biennial PATHway reporting, professional standing, and lifelong learning - plus a choice between the standard CME route (70 qualifying credits per two-year period, at least 80% related to scope of practice) or ABPath CertLink, a quarterly assessment requiring a cumulative performance of at least 60% over four years. These ongoing requirements apply to ABPath diplomates; ABMGG diplomates follow their own issuing board's maintenance rules. If you're still weighing whether the entire process is worth the investment, the ROI analysis and MGP Pass Rate data can help you decide, and you can start testing your domain knowledge right now with practice questions modeled on this blueprint.
Frequently Asked Questions
Ready to pass your MGP exam?
Put this into practice with free MGP questions across every exam domain.